Integrating business, investment, and philanthropy to make a difference
How one family in the life sciences industry leverages business, strategic investments, and nonprofit initiatives to improve health – plus their five keys to success. ...
Thierry Mauvernay is President of Après-demain, the parent company of Debiopharm, a Swiss, privately owned, biopharmaceutical company founded by his father over 40 years ago. Après-demain invests in a variety of industries including companies impacting sustainable energy, education, food, and services to individuals with real estate. Mauvernay is also Chairman of the investment committee of Debiopharm Innovation Fund. He holds a Master of Science in Economics and Marketing and an MBA from the Institut d’Administration des Entreprises.
Explore first person business intelligence from top minds curated for a global executive audience
Share